Dampening abnormal fight or flight reflex may delay HD onset and reduces symptom worsening

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer. The findings mark another success for a therapy which has overcome many hurdles in the almost 20 years UI researchers have persevered to demonstrate its benefit for cancer patients.